Survival analysis of the SpliceSeq and OncoSplicing database show that stomach adenocarcinoma patients with lower PSI (Percent spliced in) of CLSTN1 had a superior overall survival than patients with high PSI (Fig. 5L). The gene discussed is CLSTN1; the disease is gastric adenocarcinoma.